Graham Dawn

Number of records: 33
SEC FilingCompany/StockTrade DateTransactionSharesAvg. PriceTotal% HoldingsGain/Loss
24-Aug-23 4:33 PM
View: 
Xenon Pharmaceuticals Inc. (XENE) 24-Aug-23Private Sale 25,000$38.70$967,500.00(50%)
50.0K to 25.0K
11-May-23 9:11 PM
View: 
Acelyrin, Inc. (SLRN) 09-May-23Purchase 15,000$18.00$270,000.00100%
0 to 15.0K
06-Oct-22 4:20 PM
View: 
Global Blood Therapeutics, ... (GBT) 05-Oct-22Disposition 5,376----(100%)
5.38K to 0
22-Jun-22 6:00 PM
View: 
Global Blood Therapeutics, ... (GBT) 21-Jun-22Market Sale (Planned) 1,908$27.24$51,982.70(26%)
7.28K to 5.38K
(7%)
16-Jun-22 6:00 PM
View: 
Global Blood Therapeutics, ... (GBT) 14-Jun-22Option Exercise 3,600----98%
3.68K to 7.28K
10-Jun-22 4:06 PM
View: 
Ptc Therapeutics, Inc. (PTCT) 09-Jun-22Sale 738$27.20$20,074.30(2%)
29.75K to 29.02K
18-May-22 4:43 PM
View: 
Adverum Biotechnologies, Inc. (ADVM) 16-May-22Private Purchase 30,000$0.85$25,578.00150%
20.0K to 50.0K
11-Jan-22 4:14 PM
View: 
Ptc Therapeutics, Inc. (PTCT) 07-Jan-22Grant 3,200----12%
27.07K to 30.27K
11-Jan-22 4:14 PM
View: 
Ptc Therapeutics, Inc. (PTCT) 07-Jan-22Market Sale 510$38.53$19,647.80(2%)
30.27K to 29.75K
21-Jun-21 4:31 PM
View: 
Global Blood Therapeutics, ... (GBT) 18-Jun-21Market Option Sale (Planned) 1,609$36.54$58,792.90(30%)
5.29K to 3.68K
21-Jun-21 4:31 PM
View: 
Global Blood Therapeutics, ... (GBT) 17-Jun-21Option Exercise 3,037----135%
2.26K to 5.29K
11-Jun-21 4:47 PM
View: 
Ptc Therapeutics, Inc. (PTCT) 09-Jun-21Market Sale 365$41.88$15,288.00(1%)
27.43K to 27.07K
(3%)
01-Apr-21 8:21 PM
View: 
Adverum Biotechnologies, Inc. (ADVM) 31-Mar-21Market Purchase 20,000$10.02$200,338.00100%
0 to 20.0K
(2%)
02-Feb-21 6:18 PM
View: 
Ptc Therapeutics, Inc. (PTCT) 01-Feb-21Market Sale 506$56.96$28,819.70(2%)
27.94K to 27.43K
< 1%
08-Jan-21 5:09 PM
View: 
Ptc Therapeutics, Inc. (PTCT) 06-Jan-21Grant 1,650----6%
26.29K to 27.94K
19-Jun-20 9:31 PM
View: 
Global Blood Therapeutics, ... (GBT) 19-Jun-20Market Option Sale (Planned) 2,544$63.94$162,663.00(53%)
4.8K to 2.26K
29%
19-Jun-20 9:31 PM
View: 
Global Blood Therapeutics, ... (GBT) 17-Jun-20Option Exercise 4,800----100%
0 to 4.8K
12-Jun-20 4:04 PM
View: 
Ptc Therapeutics, Inc. (PTCT) 11-Jun-20Market Sale 364$48.36$17,603.00(1%)
26.65K to 26.29K
31-Jan-20 4:36 PM
View: 
Ptc Therapeutics, Inc. (PTCT) 29-Jan-20Grant 1,650----7%
25.0K to 26.65K
21-Dec-18 12:48 PM
View: 
Endocyte, Inc. (ECYT) 21-Dec-18Disposition 7,050$24.00$169,200.00(100%)
7.05K to 0
< 1%
04-May-18 5:03 PM
View: 
Endocyte, Inc. (ECYT) 03-May-18Grant 7,050----100%
0 to 7.05K
15-Aug-17 4:54 PM
View: 
Xenon Pharmaceuticals Inc. (XENE) 14-Aug-17Market Purchase 50,000$2.82$140,770.00100%
0 to 50.0K
103%
24-May-17 4:17 PM
View: 
Ptc Therapeutics, Inc. (PTCT) 23-May-17Market Purchase 25,000$13.49$337,230.00100%
0 to 25.0K
120%
30-Sep-16 5:55 PM
View: 
Medivation, Inc. (MDVN) 28-Sep-16Disposition (change in control) 21,206----(100%)
21.21K to 0
23-Jun-16 8:42 PM
View: 
Medivation, Inc. (MDVN) 22-Jun-16Grant 2,972----16%
18.23K to 21.21K
16-Mar-16 5:06 PM
View: 
Medivation, Inc. (MDVN) 14-Mar-16Market Sale 6,000$38.90$233,400.00(25%)
24.23K to 18.23K
(109%)
08-Sep-15 7:39 PM
View: 
Medivation, Inc. (MDVN) 08-Sep-15Market Sale (Planned) 3,100$89.15$276,365.00(20%)
15.22K to 12.12K
9%
18-Jun-15 6:47 PM
View: 
Medivation, Inc. (MDVN) 16-Jun-15Grant 1,578----12%
13.64K to 15.22K
04-Mar-15 9:22 PM
View: 
Medivation, Inc. (MDVN) 02-Mar-15Market Sale 3,350$119.75$401,163.00(20%)
16.99K to 13.64K
32%
16-Oct-14 6:02 PM
View: 
Medivation, Inc. (MDVN) 15-Oct-14Grant 3,682----28%
13.31K to 16.99K
01-Jul-14 4:56 PM
View: 
Medivation, Inc. (MDVN) 27-Jun-14Grant 2,250----20%
11.06K to 13.31K
02-Jul-13 4:54 PM
View: 
Medivation, Inc. (MDVN) 28-Jun-13Grant 3,557----47%
7.5K to 11.06K
23-Apr-13 5:35 PM
View: 
Medivation, Inc. (MDVN) 22-Apr-13Grant 7,500----(50%)
15.0K to 7.5K